Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Larimar Therapeutics, Inc.LRMR · Entity 5634 | Chief Financial Officer | January 26, 2026 | January 27, 2026 |
| ORASURE TECHNOLOGIES INCOSUR · Entity 6152 | Director | August 12, 2022 | August 16, 2022 |
| Societal CDMO, Inc.REPH · Entity 92137 | Chief Operating Officer | January 18, 2019 | February 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Larimar Therapeutics, Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,785 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 37,604 · Balance 215,785 F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.60 · Expires 2036-01-26 | Direct | 225,622 |
Reported balance
After 2026-01-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-26 · Grant · Acquired 225,622 · Balance 225,622 F2: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
ORASURE TECHNOLOGIES INC
Report date August 12, 2022 · Filed August 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,823 |
Reported balance
After 2022-08-12 transaction · row 1
1 source rowRow 1 · 2022-08-12 · Purchase · Acquired 12,000 · Balance 111,823 F1: Represents shares of Common Stock purchased in the open market on August 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock purchased in the open market on August 12, 2022.
Societal CDMO, Inc.
Report date January 18, 2019 · Filed February 19, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,855 |
Last balance in matching sequence
After 2019-01-18 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-01-18 · Grant · Acquired 14,464 · Balance 41,237 F1: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. Row 2 · 2019-01-18 · Exercise / conversion · Acquired 6,400 · Balance 47,637 F2: Restricted stock units convert into common stock on a one-for-one basis. Row 3 · 2019-01-18 · Tax withholding · Disposed 1,782 · Balance 45,855 F3: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.99 · Expires 2029-01-18 | Direct | 67,500 |
Reported balance
After 2019-01-18 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2019-01-18 · Grant · Acquired 67,500 · Balance 67,500 F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. F4: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,800 |
Reported balance
After 2019-01-18 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2019-01-18 · Exercise / conversion · Disposed 6,400 · Balance 12,800 F2: Restricted stock units convert into common stock on a one-for-one basis. F5: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units..
F4: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
F5: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2017 Filed Feb 13, 2017 21:37 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | SaleCommon stock | 10,000 | $10.06 | $100,600.00 |
DisclosureSEC source: 0001209784-17-000018 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,079 F1 · kind: Sale pursuant to a predetermined sales plan, entered into on February 27, 2015, under Rule 10b5-1 of the Securities and Exchange Act of 1934. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 23:14 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Exercise / conversionNonqualified stock options · Derivative | 15,000 | $0.00 Strike: $8.28 | $0.00 |
DisclosureSEC source: 0001209784-17-000004 · edgar.xml · derivative · entry 3 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 15,000 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Nonqualified stock options granted on February 1, 2007, vesting and exercisable on a monthly basis, over the 12 months immediatley following the grant date. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 23:14 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | SaleCommon stock | 15,000 | $8.78 | $131,700.00 |
DisclosureSEC source: 0001209784-17-000004 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,079 F1 · kind: Sale pursuant to a predetermined sales plan, entered into on February 27, 2015, under Rule 10b5-1 of the Securities and Exchange Act of 1934. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 23:14 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Exercise / conversionCommon stock | 15,000 | $8.28 | $124,125.00 |
DisclosureSEC source: 0001209784-17-000004 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 15:43 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantRestricted Stock Units · Derivative | 25,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-17-000211 · edgar.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,600 Underlying: Common Stock · 25,600 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 18, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 18, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 15:43 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 35,800 | $0.00 Strike: $7.33 | $0.00 |
DisclosureSEC source: 0001123292-17-000211 · edgar.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,800 Underlying: Common Stock · 35,800 shares Expires 2027-01-18 F1 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.